Eurofarma among the best pharmacies in Brazil
Published in: October 25, 2018
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, October 25, 2018 – On the night of Tuesday, the 25th, we had the 7th edition of the Época Negócios 360º award, an yearbook the Globo Publisher, which elects the best companies in the country.
In partnership with the Dom Cabral Foundation and Boa Vista SCPC, the guide ranks companies from different business segments, evaluating them in six dimensions: Financial Performance, Corporate Governance, Sustainability, Innovation, People and Future Vision.
Among the 337 companies evaluated, Eurofarma won 17th place in the overall ranking, going 17 places upward in relation to the previous year. In the ranking that includes only practices – excluding the financial performance of organizations – Eurofarma appeared in the 32nd position, having ascended 18 places. In the "Pharmaceuticals" ranking, it was in the 4th position, with a highlight to the 2nd place in Sustainability. In our industry, the winner was Aché, followed by Novartis, Cristália, Eurofarma and Hypera.
Ambev was elected the company of the year and the publication emphasized its financial health and good management.
About Eurofarma Brazil
With 46 years of existence, the Eurofarma Group is the first Brazilian pharmaceutical multinational with 100% national capital, being recognized by the medical community and society for promoting access to health and quality of life with a fair price, quality and innovative treatments.
Present in 20 countries, it operates in the area of Medical Prescription and Non Prescription, Generics, Hospital, Biddings, Oncology, Veterinary and Services for segments of third parties. In Brazil, the portfolio is represented by 335 brands in 844 presentations, including 28 medical specialties and 148 therapeutic classes.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Eurofarma
Stephanie Van Sebroeck +55 11 5090-8600 ext. 8369 – stephanie@gaspar.com.br
Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br
In partnership with the Dom Cabral Foundation and Boa Vista SCPC, the guide ranks companies from different business segments, evaluating them in six dimensions: Financial Performance, Corporate Governance, Sustainability, Innovation, People and Future Vision.
Among the 337 companies evaluated, Eurofarma won 17th place in the overall ranking, going 17 places upward in relation to the previous year. In the ranking that includes only practices – excluding the financial performance of organizations – Eurofarma appeared in the 32nd position, having ascended 18 places. In the "Pharmaceuticals" ranking, it was in the 4th position, with a highlight to the 2nd place in Sustainability. In our industry, the winner was Aché, followed by Novartis, Cristália, Eurofarma and Hypera.
Ambev was elected the company of the year and the publication emphasized its financial health and good management.
About Eurofarma Brazil
With 46 years of existence, the Eurofarma Group is the first Brazilian pharmaceutical multinational with 100% national capital, being recognized by the medical community and society for promoting access to health and quality of life with a fair price, quality and innovative treatments.
Present in 20 countries, it operates in the area of Medical Prescription and Non Prescription, Generics, Hospital, Biddings, Oncology, Veterinary and Services for segments of third parties. In Brazil, the portfolio is represented by 335 brands in 844 presentations, including 28 medical specialties and 148 therapeutic classes.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Eurofarma
Stephanie Van Sebroeck +55 11 5090-8600 ext. 8369 – stephanie@gaspar.com.br
Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br